Jun 13 2016 04 02 pm mt a risky adult stem cell clinical trial in canada has proven effective in stopping and even reversing the symptoms in patients with severe cases of multiple.
Ms and stem cell research 2016 canada.
In canadian stem.
Mark freedman ottawa hospital.
It also built on earlier research examining this approach to treating ms such as a rigorous 2016 study out of canada in which 70 percent of the 24 patients who received chemotherapy and stem cell.
The discovered potential of mesenchymal stem cells msc in treating multiple sclerosis ms has culminated in the launch of mescams mesenchymal stem cell therapy for canadian ms patients a phase ii clinical trial that is funded in part by the ms scientific research foundation research manitoba and a w food services of canada inc.
Stem cell transplants have shown good short term results in ms patients but the symptoms always returned.
The study was funded by the ms society of canada and multiple sclerosis scientific research foundation.
Mark freedman ottawa hospital research.
A radical and risky stem cell therapy has been shown to halt and even reverse some of the symptoms of those worst affected by multiple sclerosis a disease that in many people has proved untreatable.
And research support from the national multiple sclerosis society.